Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3

BackgroundPhotodynamic therapy (PDT) has been described to effectively reduce or delay severe vision loss in eyes with predominantly classic form of choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). Optical coherence tomography 3 (OCT3) is a non-invasive diagnostic procedure which provides information about retinal thickness and volume at the posterior pole, as well as about the presence of certain structures under the retina.MethodsProspective interventional study. Eleven eyes (9 patients) with AMD and CNV were treated with Verteporfin PDT. A complete ophthalmologic examination was performed. Fluorescein angiography (FA) and OCT3 scans were performed before treatment and 1, 2, 4, and 12 weeks after it.ResultsTwo different patterns of changes were observed. One group (7 eyes) showed changes in the amount of subretinal fluid (decrease, increase, and finally stable decrease), with a reduction in the CNV and the appearance of a subretinal band of hyperreflective tissue. The second group (4 eyes) showed little or no changes in retinal thickness, fluid, or reflectivity.ConclusionChanges observed in OCT3 scans represent variations in retinal thickness, fluid, and CNV after PDT. OCT3 provides a useful tool in the follow-up and measurement of changes appeared in eyes with CNV associated to AMD after treatment with PDT.

[1]  D. Chauhan,et al.  The interpretation of optical coherence tomography images of the retina. , 1999, Investigative ophthalmology & visual science.

[2]  J. Fujimoto,et al.  Optical coherence tomography of the human retina. , 1995, Archives of ophthalmology.

[3]  Carmen A Puliafito,et al.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. , 2002, American journal of ophthalmology.

[4]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[5]  Eric A. Swanson,et al.  Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .

[6]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.

[7]  A Yoshida,et al.  RETINAL THICKNESS MEASUREMENTS WITH OPTICAL COHERENCE TOMOGRAPHY AND THE SCANNING RETINAL THICKNESS ANALYZER , 2001, Retina.

[8]  M. Uyama,et al.  Occult retinal pigment epithelial detachment in hyperviscosity syndrome. , 2000, Ophthalmic surgery and lasers.

[9]  P. Beaumont,et al.  CASE SERIES OUTCOMES AT 1 WEEK FOLLOWING VERTEPORFIN PHOTODYNAMIC THERAPY , 2003, Retina.

[10]  J. Duker,et al.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.

[11]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.

[12]  U. Schmidt-Erfurth,et al.  Sequence of early vascular events after photodynamic therapy. , 2003, Investigative ophthalmology & visual science.

[13]  M. Blumenkranz,et al.  Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. , 2003, American journal of ophthalmology.

[14]  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .